AbbVie Inc (ABBV)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	4,863,000	6,514,000	8,685,000	7,585,000	11,836,000	13,407,000	12,637,000	12,479,000	11,542,000	7,534,000	6,663,000	5,159,000	4,616,000	7,381,000	6,957,000	8,436,000	7,882,000	3,255,000	4,118,000	5,360,000
Total assets	US$ in thousands	134,711,000	136,221,000	135,367,000	134,544,000	138,805,000	141,325,000	143,186,000	143,211,000	146,529,000	148,858,000	147,972,000	150,501,000	150,565,000	149,621,000	149,530,000	91,199,000	89,115,000	59,441,000	57,142,000	56,769,000
ROA		3.61%	4.78%	6.42%	5.64%	8.53%	9.49%	8.83%	8.71%	7.88%	5.06%	4.50%	3.43%	3.07%	4.93%	4.65%	9.25%	8.84%	5.48%	7.21%	9.44%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $4,863,000K ÷ $134,711,000K
= 3.61%

Analyzing Abbvie Inc's return on assets (ROA) over the past eight quarters reveals fluctuations in the company's efficiency in generating profits from its assets. ROA peaked at 9.44% in Q3 2022 and has experienced a gradual decline since then. In the most recent quarter, Q4 2023, ROA stands at 3.58%, marking a significant decrease from the previous quarter's 4.76%. Despite this decline, the company's ROA levels remain above 3% consistently, indicating that Abbvie Inc continues to effectively utilize its assets to generate profits, albeit with some volatility in performance. Further analysis is recommended to understand the underlying factors impacting the company's ROA trend and to assess its long-term sustainability.